RxDoctor Payments Data

Lisa Berkowitz

Psychiatric/Mental Health · Doylestown, PANPI 1538425913

Payments from drug & device makers

$5,000in general payments, 2019–2025

Across 240 payments — averaging $20.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$775
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$722
  • Takeda Pharmaceuticals U.S.A., Inc.$335
  • Corium, LLC$263
  • Otsuka America Pharmaceutical, Inc.$236
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$5,000100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,000 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine12$72,039
VraylarCariprazine Hcl26$36,909
Abilify MaintenaAripiprazole11$22,569
Lisdexamfetamine Dimesylate15$3,707
Clorazepate Dipotassium12$1,155
Venlafaxine Hcl ErVenlafaxine Hcl80$1,076
Desvenlafaxine Succinate ErDesvenlafaxine Succinate46$1,047
Bupropion XlBupropion Hcl56$1,035
Naltrexone Hcl18$1,023
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl17$907
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine30$777
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine30$770
Quetiapine Fumarate47$680
Olanzapine30$617
Buspirone Hcl26$600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$20$72,03912 claims
AbbVieVraylar$1,549$36,90926 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$236$22,56911 claims
Almatica Pharma LLCSertraline Hcl$57$40836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Doylestown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →